A Profit-Resistant Vaccine

NEW YORK - News yesterday that the British drug regulatory authority lifted the suspension of pharmaceutical company Chiron's license to manufacture the Fluvirin influenza vaccine sent its stock up over 7%.

Continue to A Profit-Resistant Vaccine on Misc sources.

Guarantee finance is a leading newssite providing news about stocks, markets, finance, mortgage rates, refinancing, home loans, equity, consolidation and currencies. Click below for more finance news.
Guarantee finance